Human genome sequence completed
October 28, 2003The project to decode the human genome has been completed two years ahead of schedule, but scientists have warned against …
GSK claims victory in US parallel import row
October 27, 2003GlaxoSmithKline has claimed victory in its controversial bid to block parallel imports of its drugs from Canada into the US.The …
Swiss franc undercuts Roche growth
October 27, 2003Sales revenues at Roche have been dealt a serious blow by currency fluctuations in the first quarter, with a strong …
Patent system damaging research
October 27, 2003The UK patent system is damaging scientific research and creating a "gold rush mentality", according to the Royal Society.The current …
Human genome sequence completed
October 27, 2003The project to decode the human genome has been completed two years ahead of schedule, but scientists have warned against …
Humira launch costs hit Abbott
October 27, 2003Abbott Labs recorded a 6% drop in profits for the first quarter of 2003 following heavy spending on the launch …
Set back for GSK in Augmentin court battle
October 27, 2003GlaxoSmithKline has suffered a set back in its bid to see off early US generic competition for antibiotic Augmentin, one …
MEPs vote to ban embryonic stem cell research
October 27, 2003European MPs have voted to ban the use of human cloning and embryonic stem cells for research purposes.The vote could …
Bipolar disorder included in NICE work programme
October 27, 2003NHS professionals are to be given new clinical guidelines in two important areas of mental health as part of NICE's …
‘Bogus disease’ argument flares up again
October 27, 2003The British Medical Journal has accused the pharmaceutical industry of creating bogus disease areas in order to sell treatments.The respected …
Exanta promise for AstraZeneca
October 27, 2003AstraZeneca's new anticoagulant Exanta has shown to be more effective than warfarin in preventing stroke in patients suffering from arrhythmia.Exanta …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
